Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress

被引:127
作者
Horsell, A
Carlsson, K
Ekman, R
Heilig, M
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Addict Ctr S, SE-14186 Huddinge, Sweden
[2] Univ Gothenburg, Dept Psychiat & Neurochem, Gothenburg, Sweden
关键词
anxiety; mRNA; NPY; plus-maze;
D O I
10.1097/00001756-199909290-00024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A single 1h restraint increases experimental anxiety in the elevated plus-maze through actions within the amygdala, while intra-amygdala administration of neuropeptide Y (NPY) has the opposite effect. Endogenous amygdala NPY expression is suppressed by single restraint, providing a possible mechanism for the anxiety-promoting action of this stressor. Here, we examined whether repeated stressor exposure might lead to an adaptation (habituation or sensitization) with regard to plus-maze behavior and glucocorticoid response, and whether this might be accompanied by altered effects of the stressor on NPY expression. Following repeated restraint (1h/day, 9-10 days), neither an anxiogenic-like effect of the stressor nor a glucocorticoid response were present. This behavioral and endocrine adaptation was accompanied by an upregulation of prepro-NPY mRNA and NPY peptide in amygdala but not in hypothalamic or cortical extracts, an effect opposite to that previously seen after a single restraint session. Thus, an up-regulation of NPY expression in the amygdala complex may be an adaptive mechanism recruited to cope with a repeated stressor. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:3003 / 3007
页数:5
相关论文
共 41 条
[21]   ANXIOLYTIC-LIKE ACTION OF NEUROPEPTIDE-Y - MEDIATION BY Y1 RECEPTORS IN AMYGDALA, AND DISSOCIATION FROM FOOD-INTAKE EFFECTS [J].
HEILIG, M ;
MCLEOD, S ;
BROT, M ;
HEINRICHS, SC ;
MENZAGHI, F ;
KOOB, GF ;
BRITTON, KT .
NEUROPSYCHOPHARMACOLOGY, 1993, 8 (04) :357-363
[22]   CENTRALLY ADMINISTERED NEUROPEPTIDE-Y (NPY) PRODUCES ANXIOLYTIC-LIKE EFFECTS IN ANIMAL ANXIETY MODELS [J].
HEILIG, M ;
SODERPALM, B ;
ENGEL, JA ;
WIDERLOV, E .
PSYCHOPHARMACOLOGY, 1989, 98 (04) :524-529
[23]   ANTISTRESS ACTION OF A CORTICOTROPIN-RELEASING FACTOR ANTAGONIST ON BEHAVIORAL REACTIVITY TO STRESSORS OF VARYING TYPE AND INTENSITY [J].
HEINRICHS, SC ;
MENZAGHI, F ;
PICH, EM ;
BALDWIN, HA ;
RASSNICK, S ;
BRITTON, KT ;
KOOB, GF .
NEUROPSYCHOPHARMACOLOGY, 1994, 11 (03) :179-186
[24]   EVIDENCE THAT THE AMYGDALA IS INVOLVED IN THE DISINHIBITORY EFFECTS OF 5-HT3-RECEPTOR ANTAGONISTS [J].
HIGGINS, GA ;
JONES, BJ ;
OAKLEY, NR ;
TYERS, MB .
PSYCHOPHARMACOLOGY, 1991, 104 (04) :545-551
[25]  
HODGES H, 1987, PSYCHOPHARMACOLOGY, V92, P491
[26]   EFFECTS OF LESIONS OF THE CENTRAL NUCLEUS OF THE AMYGDALA ON ANXIETY-LIKE BEHAVIORS IN THE RAT [J].
KOPCHIA, KL ;
ALTMAN, HJ ;
COMMISSARIS, RL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (02) :453-461
[27]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[28]   CLONING, CHARACTERIZATION, AND DNA-SEQUENCE OF A HUMAN CDNA-ENCODING NEUROPEPTIDE TYROSINE [J].
MINTH, CD ;
BLOOM, SR ;
POLAK, JM ;
DIXON, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (14) :4577-4581
[29]   Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions [J].
Moller, C ;
Wiklund, L ;
Sommer, W ;
Thorsell, A ;
Heilig, M .
BRAIN RESEARCH, 1997, 760 (1-2) :94-101
[30]   A neuromodulatory role for the human amygdala in processing emotional facial expressions [J].
Morris, JS ;
Friston, KJ ;
Büchel, C ;
Frith, CD ;
Young, AW ;
Calder, AJ ;
Dolan, RJ .
BRAIN, 1998, 121 :47-57